These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22780561)

  • 1. Emerging drugs for the treatment of sepsis.
    Kotsaki A; Giamarellos-Bourboulis EJ
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):379-91. PubMed ID: 22780561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The failure of biologics in sepsis: where do we stand?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S45-7. PubMed ID: 23664229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for the treatment of sepsis.
    Heming N; Lamothe L; Ambrosi X; Annane D
    Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory therapies for sepsis: unexpected effects with macrolides.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S39-43. PubMed ID: 18707849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to innate immunity: severe sepsis and septic shock.
    Lolis E; Bucala R
    Nat Rev Drug Discov; 2003 Aug; 2(8):635-45. PubMed ID: 12904813
    [No Abstract]   [Full Text] [Related]  

  • 12. Is neuroimmunomodulation a future therapeutic approach for sepsis?
    Kumar V; Sharma A
    Int Immunopharmacol; 2010 Jan; 10(1):9-17. PubMed ID: 19840870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why have clinical trials in sepsis failed?
    Marshall JC
    Trends Mol Med; 2014 Apr; 20(4):195-203. PubMed ID: 24581450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The staging of sepsis: understanding heterogeneity in treatment efficacy.
    Marshall JC
    Crit Care; 2005; 9(6):626-8. PubMed ID: 16356249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to severe bacterial infections: consequences for therapy.
    Giamarellos-Bourboulis EJ; Raftogiannis M
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):369-80. PubMed ID: 22397569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases].
    Yehudai D; Vadasz Z
    Harefuah; 2012 Mar; 151(3):171-4, 188. PubMed ID: 22519268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulating strategies in the treatment of sepsis].
    Schultz MJ; van der Poll T
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2530-3. PubMed ID: 12532664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.